Euromedis Groupe (ALEMG.PA)
EUR 4.45
(0.23%)
EUR 4.45
(0.23%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 13.11 Million EUR | 320.16% |
| 2022 | -5.95 Million EUR | -363.96% |
| 2021 | 2.25 Million EUR | -90.05% |
| 2020 | 22.66 Million EUR | 697.05% |
| 2019 | -3.79 Million EUR | 22.85% |
| 2018 | -4.91 Million EUR | -3269.86% |
| 2017 | -146 Thousand EUR | -114.5% |
| 2016 | 1 Million EUR | -59.28% |
| 2015 | 2.47 Million EUR | -3.13% |
| 2014 | 2.55 Million EUR | 16.2% |
| 2013 | 2.19 Million EUR | 103.61% |
| 2012 | 1.07 Million EUR | 231.11% |
| 2011 | -823 Thousand EUR | -201.73% |
| 2010 | 809 Thousand EUR | 132.08% |
| 2009 | -2.52 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -532 Thousand EUR | 0.0% |
| 2023 Q4 | 9.33 Million EUR | 0.0% |
| 2023 Q3 | 9.33 Million EUR | 267.77% |
| 2023 Q2 | -5.56 Million EUR | -100.0% |
| 2023 Q1 | -2.78 Million EUR | -4898.28% |
| 2023 FY | 13.11 Million EUR | 320.16% |
| 2022 FY | -5.95 Million EUR | -363.96% |
| 2022 Q1 | -2.99 Million EUR | -84.91% |
| 2022 Q2 | -5.99 Million EUR | -100.0% |
| 2022 Q3 | 29 Thousand EUR | 100.48% |
| 2022 Q4 | 58 Thousand EUR | 100.0% |
| 2021 FY | 2.25 Million EUR | -90.05% |
| 2021 Q1 | 1.92 Million EUR | -90.21% |
| 2021 Q2 | 3.87 Million EUR | 101.4% |
| 2021 Q3 | -796.5 Thousand EUR | -120.55% |
| 2021 Q4 | -1.62 Million EUR | -103.39% |
| 2020 FY | 22.66 Million EUR | 697.05% |
| 2020 Q1 | 1.62 Million EUR | 156.96% |
| 2020 Q2 | 3.24 Million EUR | 100.0% |
| 2020 Q3 | 9.7 Million EUR | 198.89% |
| 2020 Q4 | 19.65 Million EUR | 102.41% |
| 2019 Q3 | -1.41 Million EUR | -49.05% |
| 2019 Q4 | -2.85 Million EUR | -101.56% |
| 2019 Q1 | -409 Thousand EUR | 0.0% |
| 2019 FY | -3.79 Million EUR | 22.85% |
| 2019 Q2 | -949 Thousand EUR | -132.03% |
| 2018 FY | -4.91 Million EUR | -3269.86% |
| 2017 Q2 | -483.5 Thousand EUR | 0.0% |
| 2017 FY | -146 Thousand EUR | -114.5% |
| 2017 Q4 | -32.5 Thousand EUR | 0.0% |
| 2017 Q3 | -32.5 Thousand EUR | 93.28% |
| 2017 Q1 | -483.5 Thousand EUR | -217.78% |
| 2016 Q2 | 186.5 Thousand EUR | 0.0% |
| 2016 FY | 1 Million EUR | -59.28% |
| 2016 Q4 | 410.5 Thousand EUR | 0.0% |
| 2016 Q1 | 186.5 Thousand EUR | -41.17% |
| 2016 Q3 | 410.5 Thousand EUR | 120.11% |
| 2015 Q4 | 317 Thousand EUR | 0.0% |
| 2015 Q3 | 317 Thousand EUR | -60.65% |
| 2015 Q2 | 805.5 Thousand EUR | 0.0% |
| 2015 FY | 2.47 Million EUR | -3.13% |
| 2015 Q1 | 805.5 Thousand EUR | 86.89% |
| 2014 Q1 | 679 Thousand EUR | 13.64% |
| 2014 Q4 | 431 Thousand EUR | 0.0% |
| 2014 Q3 | 431 Thousand EUR | -36.52% |
| 2014 FY | 2.55 Million EUR | 16.2% |
| 2014 Q2 | 679 Thousand EUR | 0.0% |
| 2013 Q1 | 642.5 Thousand EUR | 40.9% |
| 2013 Q3 | 597.5 Thousand EUR | -7.0% |
| 2013 Q4 | 597.5 Thousand EUR | 0.0% |
| 2013 FY | 2.19 Million EUR | 103.61% |
| 2013 Q2 | 642.5 Thousand EUR | 0.0% |
| 2012 Q4 | 456 Thousand EUR | 0.0% |
| 2012 Q2 | 254 Thousand EUR | 0.0% |
| 2012 FY | 1.07 Million EUR | 231.11% |
| 2012 Q1 | 254 Thousand EUR | -11.03% |
| 2012 Q3 | 456 Thousand EUR | 79.53% |
| 2011 Q4 | 285.5 Thousand EUR | 0.0% |
| 2011 Q3 | 285.5 Thousand EUR | 0.0% |
| 2011 FY | -823 Thousand EUR | -201.73% |
| 2010 FY | 809 Thousand EUR | 132.08% |
| 2009 FY | -2.52 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Affluent Medical SA | -15.65 Million EUR | 183.756% |
| Bluelinea Société Anonyme | -1.62 Million EUR | 909.279% |
| Carmat SA | -53.86 Million EUR | 124.337% |
| Diagnostic Medical Systems S.A. | -4.94 Million EUR | 365.069% |
| Eurobio Scientific Société anonyme | 4.83 Million EUR | -171.154% |
| Ikonisys S.A. | -2.26 Million EUR | 678.147% |
| Implanet S.A. | -6.67 Million EUR | 296.38% |
| Median Technologies SA | -22.98 Million EUR | 157.046% |
| SpineGuard SA | -4.18 Million EUR | 413.388% |
| Theraclion SA | -3.67 Million EUR | 456.743% |
| Euroapi S.A. | -189.7 Million EUR | 106.911% |
| Guerbet SA | 23.86 Million EUR | 45.067% |
| Ion Beam Applications SA | -9.11 Million EUR | 243.911% |
| Koninklijke Philips N.V. | -466 Million EUR | 102.813% |
| Sequana Medical NV | -32.56 Million EUR | 140.261% |